HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC labeling rules may negatively affect ADA Seal of Acceptance program, assn. says.

This article was originally published in The Rose Sheet

Executive Summary

OTC LABELING RULES MAY AFFECT ADA SEAL OF ACCEPTANCE PROGRAM, the American Dental Association claims in Oct. 3 comments on FDA's proposed regulations for revised OTC drug labeling. While expressing support for the rulemaking in general, ADA notes it is "concerned...that the section of the rule establishing requirements for labeling content (201.66(c)) could have a negative effect on the ADA Seal of Acceptance program and the public and profession it serves." FDA published the proposed rule in the Feb. 27 Federal Register ("The Rose Sheet" March 3, pp. 11-13).
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS004786

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel